Terms: = Lymphoma AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2
52 results:
1. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract] [Full Text] [Related]
2. Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
Chen Z; Huang H; Hong H; Huang H; Weng H; Yu L; Xiao J; Wang Z; Fang X; Yao Y; Yue JX; Lin T
Genome Med; 2024 Apr; 16(1):48. PubMed ID: 38566223
[TBL] [Abstract] [Full Text] [Related]
3. Challenging our understanding of B-cell lymphomagenesis and risk: Paediatric high-grade B-cell lymphoma, not otherwise specified with a ddx3x::MLLT10 fusion and an IGH deletion.
Hare L; Trotman J; Tarpey P; Hook E; Burke GAA;
Pediatr Blood Cancer; 2024 Mar; 71(3):e30810. PubMed ID: 38102963
[TBL] [Abstract] [Full Text] [Related]
4. Establishment of ganglioside GD2-expressing extranodal NK/T-cell lymphoma cell line with scRNA-seq analysis.
Sato S; Ishii M; Tachibana K; Furukawa Y; Toyota T; Kinoshita S; Azusawa Y; Ando J; Ando M
Exp Hematol; 2024 Feb; 130():104132. PubMed ID: 38029851
[TBL] [Abstract] [Full Text] [Related]
5. Primary mediastinal/thymic diffuse large B-cell lymphoma: a population-based study on incidence and survival.
Zhou H; Liu Q; Lu S; Zou L
Ann Hematol; 2023 Jul; 102(7):1879-1886. PubMed ID: 37074378
[TBL] [Abstract] [Full Text] [Related]
6. Decoding the molecular heterogeneity of pediatric monomorphic post-solid organ transplant lymphoproliferative disorders.
Salmerón-Villalobos J; Castrejón-de-Anta N; Guerra-García P; Ramis-Zaldivar JE; López-Guerra M; Mato S; Colomer D; Diaz-Crespo F; Menarguez J; Garrido-Pontnou M; Andrés M; García-Fernández E; Llavador M; Frigola G; García N; González-Farré B; Martín-Guerrero I; Garrido-Colino C; Astigarraga I; Fernández A; Verdú-Amorós J; González-Muñíz S; González B; Celis V; Campo E; Balagué O; Salaverria I
Blood; 2023 Aug; 142(5):434-445. PubMed ID: 37053555
[TBL] [Abstract] [Full Text] [Related]
7. Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma.
Shen R; Fu D; Dong L; Zhang MC; Shi Q; Shi ZY; Cheng S; Wang L; Xu PP; Zhao WL
Signal Transduct Target Ther; 2023 Apr; 8(1):145. PubMed ID: 37032379
[TBL] [Abstract] [Full Text] [Related]
8. High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases.
Shestakova A; Shao L; Smith LB; Ryan R; Bedell V; Murata-Collins J; Zhang W; Perry AM; Song JY
Hum Pathol; 2023 Jun; 136():34-43. PubMed ID: 36997031
[TBL] [Abstract] [Full Text] [Related]
9. Characteristics and prognosis of rrDLBCL with TP53 mutations and a high-risk subgroup represented by the co-mutations of ddx3x-TP53.
Gao F; Hu K; Zheng P; Shi H; Ke X
Cancer Med; 2023 May; 12(9):10267-10279. PubMed ID: 36971051
[TBL] [Abstract] [Full Text] [Related]
10. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.
Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q
Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661
[TBL] [Abstract] [Full Text] [Related]
11. Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma.
Thomas N; Dreval K; Gerhard DS; Hilton LK; Abramson JS; Ambinder RF; Barta S; Bartlett NL; Bethony J; Bhatia K; Bowen J; Bryan AC; Cesarman E; Casper C; Chadburn A; Cruz M; Dittmer DP; Dyer MA; Farinha P; Gastier-Foster JM; Gerrie AS; Grande BM; Greiner T; Griner NB; Gross TG; Harris NL; Irvin JD; Jaffe ES; Henry D; Huppi R; Leal FE; Lee MS; Martin JP; Martin MR; Mbulaiteye SM; Mitsuyasu R; Morris V; Mullighan CG; Mungall AJ; Mungall K; Mutyaba I; Nokta M; Namirembe C; Noy A; Ogwang MD; Omoding A; Orem J; Ott G; Petrello H; Pittaluga S; Phelan JD; Ramos JC; Ratner L; Reynolds SJ; Rubinstein PG; Sissolak G; Slack G; Soudi S; Swerdlow SH; Traverse-Glehen A; Wilson WH; Wong J; Yarchoan R; ZenKlusen JC; Marra MA; Staudt LM; Scott DW; Morin RD
Blood; 2023 Feb; 141(8):904-916. PubMed ID: 36201743
[TBL] [Abstract] [Full Text] [Related]
12. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
[TBL] [Abstract] [Full Text] [Related]
13. Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association.
Oishi N; Satou A; Miyaoka M; Kawashima I; Segawa T; Miyake K; Mochizuki K; Kirito K; Feldman AL; Nakamura N; Kondo T
Blood Adv; 2023 Jan; 7(1):178-189. PubMed ID: 35882439
[TBL] [Abstract] [Full Text] [Related]
14. The X-Linked Helicase ddx3x Is Required for Lymphoid Differentiation and MYC-Driven lymphomagenesis.
Lacroix M; Beauchemin H; Fraszczak J; Ross J; Shooshtarizadeh P; Chen R; Möröy T
Cancer Res; 2022 Sep; 82(17):3172-3186. PubMed ID: 35815807
[TBL] [Abstract] [Full Text] [Related]
15. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age.
Burkhardt B; Michgehl U; Rohde J; Erdmann T; Berning P; Reutter K; Rohde M; Borkhardt A; Burmeister T; Dave S; Tzankov A; Dugas M; Sandmann S; Fend F; Finger J; Mueller S; Gökbuget N; Haferlach T; Kern W; Hartmann W; Klapper W; Oschlies I; Richter J; Kontny U; Lutz M; Maecker-Kolhoff B; Ott G; Rosenwald A; Siebert R; von Stackelberg A; Strahm B; Woessmann W; Zimmermann M; Zapukhlyak M; Grau M; Lenz G
Nat Commun; 2022 Jul; 13(1):3881. PubMed ID: 35794096
[TBL] [Abstract] [Full Text] [Related]
16. Mortality among Tennessee Eastman Corporation (TEC) uranium processing workers, 1943-2019.
Boice JD; Cohen SS; Mumma MT; Golden AP; Howard SC; Girardi DJ; Ellis ED; Bellamy MB; Dauer LT; Eckerman KF; Leggett RW
Int J Radiat Biol; 2023; 99(2):208-228. PubMed ID: 35758985
[TBL] [Abstract] [Full Text] [Related]
17. The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications.
Giannuzzi D; Marconato L; Fanelli A; Licenziato L; De Maria R; Rinaldi A; Rotta L; Rouquet N; Birolo G; Fariselli P; Mensah AA; Bertoni F; Aresu L
Lab Anim (NY); 2022 Jul; 51(7):191-202. PubMed ID: 35726023
[TBL] [Abstract] [Full Text] [Related]
18. Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements.
Frauenfeld L; Castrejon-de-Anta N; Ramis-Zaldivar JE; Streich S; Salmerón-Villalobos J; Otto F; Mayer AK; Steinhilber J; Pinyol M; Mankel B; Ramsower C; Bonzheim I; Fend F; Rimsza LM; Salaverria I; Campo E; Balagué O; Quintanilla-Martinez L
Blood Adv; 2022 Apr; 6(7):2361-2372. PubMed ID: 34654055
[TBL] [Abstract] [Full Text] [Related]
19. Sex, life, and death in MYC-driven lymphomagenesis.
Dang CV
Mol Cell; 2021 Oct; 81(19):3886-3887. PubMed ID: 34624215
[TBL] [Abstract] [Full Text] [Related]
20. Sequential inverse dysregulation of the RNA helicases ddx3x and ddx3Y facilitates MYC-driven lymphomagenesis.
Gong C; Krupka JA; Gao J; Grigoropoulos NF; Giotopoulos G; Asby R; Screen M; Usheva Z; Cucco F; Barrans S; Painter D; Zaini NBM; Haupl B; Bornelöv S; Ruiz De Los Mozos I; Meng W; Zhou P; Blain AE; Forde S; Matthews J; Khim Tan MG; Burke GAA; Sze SK; Beer P; Burton C; Campbell P; Rand V; Turner SD; Ule J; Roman E; Tooze R; Oellerich T; Huntly BJ; Turner M; Du MQ; Samarajiwa SA; Hodson DJ
Mol Cell; 2021 Oct; 81(19):4059-4075.e11. PubMed ID: 34437837
[TBL] [Abstract] [Full Text] [Related]
[Next]
